항상 최고의 진료를
약속합니다

외과 강성수 교수

일반진료
오전 진료 진료 진료 2,4주
오후 진료 진료

전문분야

유방암, 양성 유방질환

교수 경력

  • 성균관대학교
  • 가톨릭관동대학교
  • 단국대학교
  • 차의과학대학교

진료 경력

  • 제일병원 외과 주임과장
  • 제일병원 진료부장, 의료기획실장
  • 차의과학대학교 일산차병원 외과 과장
  • 차의과학대학교 일산차병원 유방센터 센터장

학회·연구·연수·수상 경력

  • 한국유방암학회 부회장
  • 대한외과학회 외과 유방질환분과 관리위원장
  • Research Fellow in Surgery, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA, U.S.A
  • 유방학(The breast) 제4판 공저

  • 언론기사·영상
  • 논문
  1. Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial. J Clin Oncol, 2019 Aug. (공저)
  2. Assessment of Quality of Life and Safety in Postmenopausal Breast Cancer Patients Receiving Letrozole as an Early Adjuvant Treatment. J Breast Cancer, 2018 June (공저)
  3. The Usefulness of Intraoperative Circumferential Frozen-Section Analysis of Lumpectomy Margins in Breast-Conserving Surgery.  J Breast Cancer, 2017 June (공저)
  4. Primary osteosarcoma of the breast: a case report. Ann Surg Treat Res. 2017 July (교신저자)
  5. Short-term outcomes of immediate breast reconstruction using an implant or tissue expander after mastectomy in breast cancer patients. Breast Cancer, 2016 Mar. (공저)
  6. The Basic Facts of Korean Breast Cancer in 2013: Results of a Nationwide Survey and Breast Cancer Registry Database. J Breast Cancer, 2016 Mar., (공저)
  7. The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled. BMC Cancer, 2016 May (공저)
  8. The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database. J Breast Cancer, 2016 June (공저)
  9. The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study. Breast Cancer Res Treat, 2015 May, (공저)
  10. 유방학(The Breast), 제 1 - 4판. (공저)